Investment Thesis
Aterian faces severe fundamental deterioration with collapsing revenues (-30.5% YoY), persistent operating losses (-19.0% margin), and negative free cash flow (-$9.9M) indicating inability to fund operations internally. The company carries excessive leverage (1.27x debt-to-equity) with long-term debt ($28.7M) nearly 4x the cash position ($7.6M), creating acute refinancing and solvency risk.
ATER Strengths
- Solid gross margin of 56.9% indicates underlying product economics remain acceptable
- Current ratio of 1.76x suggests adequate short-term liquidity to meet immediate obligations
- Positive insider activity with 5 Form 4 filings suggests management believes in turnaround potential
ATER Risks
- Revenue collapse of 30.5% YoY combined with negative operating income indicates structural demand problems or loss of competitive position
- Negative operating cash flow of -$9.9M with zero positive FCF means company is consuming cash and cannot self-fund operations or debt service
- Debt burden of $28.7M with interest coverage ratio of -13.7x creates severe default risk; company cannot cover interest payments from earnings
- Negative ROE (-48.8%) and ROA (-27.5%) indicate shareholder capital is being destroyed; equity value deteriorating rapidly
- Quick ratio of 0.77x reveals liquidity stress when inventory is excluded; working capital position deteriorating
Key Metrics to Watch
- Operating cash flow trend - critical to assess if company can survive without external financing
- Revenue stabilization - must confirm bottom is reached and demand is returning
- Debt maturity schedule and refinancing capacity - determines solvency timeline
- Gross margin sustainability - key to assessing if cost structure changes are driving losses
ATER Financial Metrics
ATER Profitability Ratios
ATER Balance Sheet & Liquidity
ATER 5-Year Financial Trend
5-Year Trend Summary: Aterian, Inc.'s revenue has declined by 23% over the 5-year period, indicating business contraction. The most recent EPS of $-6.67 indicates the company is currently unprofitable.
ATER Growth Metrics (YoY)
ATER Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $19.0M | -$1.8M | $-0.25 |
| Q2 2025 | $19.5M | -$3.6M | $-0.52 |
| Q1 2025 | $15.4M | -$3.9M | $-0.52 |
| Q3 2024 | $26.2M | -$1.8M | $-0.25 |
| Q2 2024 | $28.0M | -$3.6M | $-0.52 |
| Q1 2024 | $20.2M | -$5.2M | $-0.76 |
| Q3 2023 | $39.7M | -$6.3M | $-0.08 |
| Q2 2023 | $35.3M | -$16.3M | $-0.26 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
ATER Capital Allocation
ATER SEC Filings
Access official SEC EDGAR filings for Aterian, Inc. (CIK: 0001757715)